A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis

On behalf of the neals consortium

Research output: Contribution to journalArticle

Abstract

Objective: Evaluate the safety and tolerability of resistance and endurance exercise in ALS participants as measured by their ability to complete this six-month study. Methods: Participants were randomized to Resistance, Endurance, or Stretching/Range of Motion (SROM the exercise regimen prescribed for most ALS patients) exercises. All exercises were performed at home with an individualized regimen designed by a physical therapist trained in ALS management. Primary outcome measures were tolerability of the exercises at 24 weeks defined by 50% of participants completing at least 50% of the prescribed exercise regimen. Secondary outcome measures included the ALSFRS-R, pulmonary FVC, and other measures of ALS function. Results: At 12 and 24 weeks, all three exercise regimens were tolerated according to our pre-specified criteria. Compliance to the prescribed exercise regimen was the highest in the resistance and SROM arms of the study. All three forms of exercise were considered safe as there were no differences in the rates of disease progression among groups. There were no differences in the secondary outcome measures and feasibility for evaluating these measures was successful. In a post-hoc analysis, there was a trend towards fewer falls in the Resistance and Endurance groups. Conclusions: This study demonstrates that SROM, resistance, and endurance exercise are all safe to be performed with the specified regimen without any worsening of outcomes as related to ALS function. All three forms of exercise were tolerated with resistance and SROM exercises showing the highest compliance over the 24 week-period.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
DOIs
StateAccepted/In press - Nov 29 2017

Fingerprint

Amyotrophic Lateral Sclerosis
Randomized Controlled Trials
Exercise
Outcome Assessment (Health Care)
Physical Therapists
Articular Range of Motion
Compliance
Disease Progression

Keywords

  • ALS
  • benefit
  • clinical trial
  • motor neuron disease
  • tolerability

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. / On behalf of the neals consortium.

In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 29.11.2017, p. 1-9.

Research output: Contribution to journalArticle

@article{3c415dffb40540cdafcb9cd07a01d816,
title = "A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis",
abstract = "Objective: Evaluate the safety and tolerability of resistance and endurance exercise in ALS participants as measured by their ability to complete this six-month study. Methods: Participants were randomized to Resistance, Endurance, or Stretching/Range of Motion (SROM the exercise regimen prescribed for most ALS patients) exercises. All exercises were performed at home with an individualized regimen designed by a physical therapist trained in ALS management. Primary outcome measures were tolerability of the exercises at 24 weeks defined by 50{\%} of participants completing at least 50{\%} of the prescribed exercise regimen. Secondary outcome measures included the ALSFRS-R, pulmonary FVC, and other measures of ALS function. Results: At 12 and 24 weeks, all three exercise regimens were tolerated according to our pre-specified criteria. Compliance to the prescribed exercise regimen was the highest in the resistance and SROM arms of the study. All three forms of exercise were considered safe as there were no differences in the rates of disease progression among groups. There were no differences in the secondary outcome measures and feasibility for evaluating these measures was successful. In a post-hoc analysis, there was a trend towards fewer falls in the Resistance and Endurance groups. Conclusions: This study demonstrates that SROM, resistance, and endurance exercise are all safe to be performed with the specified regimen without any worsening of outcomes as related to ALS function. All three forms of exercise were tolerated with resistance and SROM exercises showing the highest compliance over the 24 week-period.",
keywords = "ALS, benefit, clinical trial, motor neuron disease, tolerability",
author = "{On behalf of the neals consortium} and Lora Clawson and Merit Cudkowicz and Lisa Krivickas and Brooks, {Benjamin R.} and Mohammed Sanjak and Peggy Allred and Nazem Atassi and AMY Swartz and Gabrielle Steinhorn and Alpa Uchil and Riley, {Kristen M.} and Hong Yu and Schoenfeld, {David A.} and Maragakis, {Nicholas J}",
year = "2017",
month = "11",
day = "29",
doi = "10.1080/21678421.2017.1404108",
language = "English (US)",
pages = "1--9",
journal = "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration",
issn = "2167-8421",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis

AU - On behalf of the neals consortium

AU - Clawson, Lora

AU - Cudkowicz, Merit

AU - Krivickas, Lisa

AU - Brooks, Benjamin R.

AU - Sanjak, Mohammed

AU - Allred, Peggy

AU - Atassi, Nazem

AU - Swartz, AMY

AU - Steinhorn, Gabrielle

AU - Uchil, Alpa

AU - Riley, Kristen M.

AU - Yu, Hong

AU - Schoenfeld, David A.

AU - Maragakis, Nicholas J

PY - 2017/11/29

Y1 - 2017/11/29

N2 - Objective: Evaluate the safety and tolerability of resistance and endurance exercise in ALS participants as measured by their ability to complete this six-month study. Methods: Participants were randomized to Resistance, Endurance, or Stretching/Range of Motion (SROM the exercise regimen prescribed for most ALS patients) exercises. All exercises were performed at home with an individualized regimen designed by a physical therapist trained in ALS management. Primary outcome measures were tolerability of the exercises at 24 weeks defined by 50% of participants completing at least 50% of the prescribed exercise regimen. Secondary outcome measures included the ALSFRS-R, pulmonary FVC, and other measures of ALS function. Results: At 12 and 24 weeks, all three exercise regimens were tolerated according to our pre-specified criteria. Compliance to the prescribed exercise regimen was the highest in the resistance and SROM arms of the study. All three forms of exercise were considered safe as there were no differences in the rates of disease progression among groups. There were no differences in the secondary outcome measures and feasibility for evaluating these measures was successful. In a post-hoc analysis, there was a trend towards fewer falls in the Resistance and Endurance groups. Conclusions: This study demonstrates that SROM, resistance, and endurance exercise are all safe to be performed with the specified regimen without any worsening of outcomes as related to ALS function. All three forms of exercise were tolerated with resistance and SROM exercises showing the highest compliance over the 24 week-period.

AB - Objective: Evaluate the safety and tolerability of resistance and endurance exercise in ALS participants as measured by their ability to complete this six-month study. Methods: Participants were randomized to Resistance, Endurance, or Stretching/Range of Motion (SROM the exercise regimen prescribed for most ALS patients) exercises. All exercises were performed at home with an individualized regimen designed by a physical therapist trained in ALS management. Primary outcome measures were tolerability of the exercises at 24 weeks defined by 50% of participants completing at least 50% of the prescribed exercise regimen. Secondary outcome measures included the ALSFRS-R, pulmonary FVC, and other measures of ALS function. Results: At 12 and 24 weeks, all three exercise regimens were tolerated according to our pre-specified criteria. Compliance to the prescribed exercise regimen was the highest in the resistance and SROM arms of the study. All three forms of exercise were considered safe as there were no differences in the rates of disease progression among groups. There were no differences in the secondary outcome measures and feasibility for evaluating these measures was successful. In a post-hoc analysis, there was a trend towards fewer falls in the Resistance and Endurance groups. Conclusions: This study demonstrates that SROM, resistance, and endurance exercise are all safe to be performed with the specified regimen without any worsening of outcomes as related to ALS function. All three forms of exercise were tolerated with resistance and SROM exercises showing the highest compliance over the 24 week-period.

KW - ALS

KW - benefit

KW - clinical trial

KW - motor neuron disease

KW - tolerability

UR - http://www.scopus.com/inward/record.url?scp=85035757147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035757147&partnerID=8YFLogxK

U2 - 10.1080/21678421.2017.1404108

DO - 10.1080/21678421.2017.1404108

M3 - Article

C2 - 29191052

AN - SCOPUS:85035757147

SP - 1

EP - 9

JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SN - 2167-8421

ER -